Inhaled studies are often perceived as technically challenging, and varied regulations around the world add another level of complexity. Understanding the guidelines, study design requirements, study timing and test article suitability will demystify and clarify inhaled studies optimizing success.
Recent increases in regulatory scrutiny and focus emphasize the importance of quality antibody reagents. The majority of biotherapeutic programs have several critical reagents that require generation, storage/management and periodic retesting.
Your source for answers to the complex challenges of cell and gene therapy development. We recently sat down with Maryland Franklin, Vice President and Enterprise Head of Cell & Gene Therapy at Labcorp Drug Development, to discuss key considerations for developing cell or gene therapies in today's quickly expanding pipeline.
Learn from Steven M Anderson, PhD, Chief Scientific Officer, Labcorp Drug Development, in our on-demand, English-subtitled webinar that discusses trends in precision medicine, various approaches and the commercialization of biomarker companion diagnostic assays.
We offer a global full-service range of safety testing and regulatory consultancy capabilities to support the human and environmental risk assessments for both chemical testing and crop protection products.
